Pharmacogenomics

Pharmacogenomics is the study of the role of genetics in drug response. It deals with the effect of genetic variation on drug response in patients by associating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Pharmacogenetics focuses on single drug-gene interactions. It helps in Improve drug safety, and reduce ADRs,Tailor treatments to meet patients' unique genetic pre-disposition, identifying optimal dosing.

 

  • Genome sequencing
  • Clinical Pharmacogenomics
  • Genomics for optimized medical prescription
  • More accurate methods of determining appropriate drug dosages
  • Advanced screening for disease

Related Conference of Pharmacogenomics

May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

A Coruna, Spain

Pharmacogenomics Conference Speakers